Company Valuation: Bio-Rad Laboratories, Inc.

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 22,439 12,460 9,399 9,182 8,212 10,309 - -
Change - -44.47% -24.57% -2.31% -10.57% 25.53% - -
Enterprise Value (EV) 1 22,439 11,868 8,992 8,730 7,874 9,560 9,344 9,202
Change - -47.11% -24.24% -2.91% -9.8% 21.41% -2.26% -1.51%
P/E 5.38x - -14.8x -5.03x 10.9x 46.9x 45.9x 46.2x
PBR - 1.27x 1.05x 1.41x 1.11x - - -
PEG - - - -0x -0x -0.7x 21.24x -65.53x
Capitalization / Revenue 7.68x 4.45x 3.52x 3.58x 3.18x 4.01x 3.91x 3.84x
EV / Revenue 7.68x 4.24x 3.37x 3.4x 3.05x 3.72x 3.55x 3.43x
EV / EBITDA 33.1x 17.8x 16.8x 18.2x 17.4x 23.3x 21.5x 20.6x
EV / EBIT 39.3x 22.7x 23.7x 26.4x 25.3x 33.3x 29.4x 28x
EV / FCF 41.9x 127x 24x - - 31.1x 29.6x 27.8x
FCF Yield 2.39% 0.79% 4.17% - - 3.21% 3.38% 3.6%
Dividend per Share 2 - - - - - - - -
Rate of return - - - - - - - -
EPS 2 140.6 - -21.82 -65.36 27.85 8.33 8.51 8.45
Distribution rate - - - - - - - -
Net sales 1 2,923 2,802 2,671 2,566 2,583 2,573 2,633 2,682
EBITDA 1 677.5 667.9 535.9 479.5 453.2 410.3 435 446.5
EBIT 1 571.2 524 378.9 331.3 311.6 287.5 318.4 328.8
Net income 1 4,246 -3,628 -637.3 -1,844 759.9 225 230 228
Net Debt 1 - -592.5 -407.6 -452.1 -337.7 -749 -965.4 -1,107
Reference price 2 755.57 420.49 322.89 328.51 302.99 390.34 390.34 390.34
Nbr of stocks (in thousands) 29,918 29,824 29,145 27,997 26,975 26,738 - -
Announcement Date 2/10/22 2/16/23 2/15/24 2/13/25 2/12/26 - - -
1USD in Million2USD
Estimates

P/E, Detailed evolution

P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
33.47x4.49x17.25x2.2% 201B
20.92x3.61x12.74x3.2% 117B
17.73x0.21x12.94x0.74% 62.6B
30.33x7.54x19.27x1.32% 52.49B
36.76x3.52x12.05x2.06% 51.69B
36.5x6.42x20.17x-.--% 33.65B
45.55x1.29x11.82x0.17% 31.27B
41.2x7.22x25.91x0.26% 24.52B
20.05x3.09x11.28x1.43% 24.05B
Average 31.39x 4.15x 15.94x 1.26% 66.43B
Weighted average by Cap. 29.96x 4.05x 15.64x 1.81%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

Year-on-year evolution of the Yield

  1. Stock Market
  2. Stocks
  3. BIO Stock
  4. BIO.B Stock
  5. Valuation Bio-Rad Laboratories, Inc.